Anika Therapeutics Inc.

NASDAQ:ANIK   2:23:03 PM EDT
23.03
-0.22 (-0.95%)
Earnings Announcements

Anika Therapeutics Q2 Adjusted Loss Per Share $0.12

Published: 08/03/2022 21:52 GMT
Anika Therapeutics Inc. (ANIK) - Anika Reports Second Quarter Fiscal 2022 Financial Results.
Q2 Adjusted Loss per Share $0.12.
Q2 Loss per Share $0.20.
Revenue in Q2 of 2022 Was $39.7 Million, Up 4%.
Revenue is expected to be $38.11 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $39.89 Million
Next Quarter EPS Guidance is expected to be -$0.13

More details on our Analysts Page.